IOVA - Iovance Biotherapeutics, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$2.00
DETAILS
HIGH:
$2.00
LOW:
$2.00
MEDIAN:
$2.00
CONSENSUS:
$2.00
DOWNSIDE:
50.98%
Institutional Holders (13F)
| GURU | SHARES | VALUE | WEIGHT % | SHARES CHG | ACTION |
|---|---|---|---|---|---|
| Cooperman | 8,016,353 | $28.1M | 0.0% | +4,186,558 | INCREASED |
Insider Trading
| DATE | INSIDER | TITLE | TYPE | SHARES | PRICE | VALUE |
|---|---|---|---|---|---|---|
| 2026-05-11 | Kirby Daniel Gordon | officer: Chief Commercial Officer | F-InKind | 2,435 | $3.70 | $9K |
| 2026-05-11 | Kirby Daniel Gordon | officer: Chief Commercial Officer | M-Exempt | 10,000 | -- | -- |
| 2026-03-09 | Kirby Daniel Gordon | officer: Chief Commercial Officer | A-Award | 132,200 | -- | -- |
| 2026-03-09 | Roche Corleen M. | officer: Chief Financial Officer | A-Award | 132,200 | -- | -- |
| 2026-03-09 | Vogt Frederick G | director, officer: Interim CEO & General Counsel | A-Award | 235,000 | -- | -- |
| 2026-03-09 | Puri Raj K. | officer: Chief Regulatory Officer | A-Award | 117,500 | -- | -- |
| 2026-03-09 | GRAF FINCKENSTEIN FRIEDRICH | officer: Chief Medical Officer | A-Award | 58,750 | -- | -- |
| 2026-03-09 | BILINSKY IGOR | officer: Chief Operating Officer | A-Award | 117,500 | -- | -- |
| 2026-03-05 | BILINSKY IGOR | officer: Chief Operating Officer | M-Exempt | 31,246 | -- | -- |
| 2026-03-05 | GRAF FINCKENSTEIN FRIEDRICH | officer: Chief Medical Officer | M-Exempt | 31,246 | -- | -- |
| 2026-03-05 | BILINSKY IGOR | officer: Chief Operating Officer | F-InKind | 16,628 | $4.58 | $76K |
| 2026-03-05 | Vogt Frederick G | director, officer: Interim CEO & General Counsel | F-InKind | 26,755 | $4.58 | $123K |
| 2026-03-05 | Vogt Frederick G | director, officer: Interim CEO & General Counsel | M-Exempt | 62,493 | -- | -- |
| 2026-03-05 | GRAF FINCKENSTEIN FRIEDRICH | officer: Chief Medical Officer | F-InKind | 16,520 | $4.58 | $76K |
| 2026-03-05 | Puri Raj K. | officer: Chief Regulatory Officer | F-InKind | 18,360 | $4.58 | $84K |
| 2026-03-05 | Puri Raj K. | officer: Chief Regulatory Officer | M-Exempt | 39,059 | -- | -- |
| 2026-03-02 | Vogt Frederick G | director, officer: Interim CEO & General Counsel | F-InKind | 22,809 | $3.79 | $86K |
| 2026-03-02 | Vogt Frederick G | director, officer: Interim CEO & General Counsel | M-Exempt | 41,669 | -- | -- |
| 2026-03-02 | Vogt Frederick G | director, officer: Interim CEO & General Counsel | M-Exempt | 10,418 | -- | -- |
| 2026-03-02 | BILINSKY IGOR | officer: Chief Operating Officer | M-Exempt | 12,307 | -- | -- |
| 2026-03-02 | BILINSKY IGOR | officer: Chief Operating Officer | F-InKind | 6,903 | $3.79 | $26K |
| 2026-03-02 | BILINSKY IGOR | officer: Chief Operating Officer | M-Exempt | 8,790 | -- | -- |
| 2026-03-02 | BILINSKY IGOR | officer: Chief Operating Officer | M-Exempt | 3,517 | -- | -- |
| 2026-03-02 | Puri Raj K. | officer: Chief Regulatory Officer | F-InKind | 2,798 | $3.79 | $11K |
| 2026-03-02 | Puri Raj K. | officer: Chief Regulatory Officer | M-Exempt | 5,470 | -- | -- |